Today, IBRX is fighting to escape its penny stock status.
Whales on Reddit (accounts with 10k+ karma) are mostly bullish, some of them expecting it to reach $6–$7 due to a successful short squeeze.
Catalyst: Saudi FDA grants accelerated approval to ImmunityBio’s ANKTIVA®.
Let's see if it reaches $6 by the end of the day.
Here is a screenshot from StocksHeat showing how the dynamic is playing out so far:
[StocksHeat screenshot showing IBRX price x mentions movement](https://preview.redd.it/kbrurwvonqdg1.png?width=2862&format=png&auto=webp&s=c5f18870cd886cd3474b4e3900c071da1672b260)
P.S. Screenshot is from https://www.stocksheat.com.